|
DHX36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62858615482264E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09029452133313E-11 |
| Normal-vs-Stage2 |
4.36379999912972E-08 |
| Normal-vs-Stage3 |
1.85784720940774E-12 |
| Normal-vs-Stage4 |
1.54559698373191E-11 |
| Stage1-vs-Stage2 |
4.444800E-01 |
| Stage1-vs-Stage3 |
6.002000E-02 |
| Stage1-vs-Stage4 |
1.861710E-02 |
| Stage2-vs-Stage3 |
5.676600E-01 |
| Stage2-vs-Stage4 |
3.127800E-01 |
| Stage3-vs-Stage4 |
5.999400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.65263375101677E-14 |
| Normal-vs-AfricanAmerican |
1.142810E-03 |
| Normal-vs-Asian |
1.89290000340847E-08 |
| Caucasian-vs-AfricanAmerican |
2.185200E-01 |
| Caucasian-vs-Asian |
7.251600E-01 |
| AfricanAmerican-vs-Asian |
2.105400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66022792472631E-13 |
| Normal-vs-Female |
1.78546066820218E-12 |
| Male-vs-Female |
2.591200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31719998744495E-09 |
| Normal-vs-Age(41-60Yrs) |
4.15223411209809E-14 |
| Normal-vs-Age(61-80Yrs) |
4.37228031557879E-12 |
| Normal-vs-Age(81-100Yrs) |
9.447300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.094400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.701600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.885800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.284600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.079800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.683400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.202600E-01 |
| Classical-VS-Follicular |
2.429700E-02 |
| Classical-VS-Other |
2.667200E-01 |
| Classical-VS-Normal |
6.33115782022742E-12 |
| Tall-VS-Follicular |
9.618400E-01 |
| Tall-VS-Other |
7.311400E-01 |
| Tall-VS-Normal |
4.98079999466938E-09 |
| Follicular-VS-Other |
7.629200E-01 |
| Follicular-VS-Normal |
5.56169554855046E-11 |
| Other-VS-Normal |
9.357100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.82631687550838E-13 |
| Normal-vs-N1 |
2.17359996668165E-09 |
| N0-vs-N1 |
4.385200E-01 |
|
|
